Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06137807

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Led by P+F Products + Features USA Inc. · Updated on 2025-06-08

50

Participants Needed

36

Research Sites

266 weeks

Total Duration

On this page

Sponsors

P

P+F Products + Features USA Inc.

Lead Sponsor

P

P+F Products + Features GmbH

Collaborating Sponsor

AI-Summary

What this Trial Is About

The TricValve® Transcatheter Bicaval Valve System is a bicaval transcatheter tricuspid valve replacement system, which includes the TricValve® Transcatheter Bicaval Valve for superior vena cava (SVC) and the TricValve® Transcatheter Bicaval Valve for inferior vena cava (IVC). The TricValve® Transcatheter Bicaval Valves are pre-mounted into the TricValve® Delivery System which is used for percutaneous access and delivery of the TricValve® Transcatheter Bicaval Valve in the vena cava. The system is a single use, sterile device compatible with all the valve sizes. The prostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. The device is made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system.

CONDITIONS

Official Title

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older at the time of signing informed consent
  • Severe tricuspid regurgitation confirmed by transthoracic echocardiogram and Core Lab
  • NYHA Class III-IVa or heart failure admission within past 6 months
  • Receiving optimal medical therapy for heart failure including a diuretic for at least 30 days prior to procedure
  • Eligible for TricValve procedure as determined by local Heart Team and IEC
  • Negative pregnancy test for females of childbearing potential
  • Capable of giving signed informed consent
Not Eligible

You will not qualify if you...

  • Recent myocardial infarction, stroke, coronary artery bypass graft, percutaneous coronary intervention, or major cardiac surgery within 90 days prior to TricValve implantation
  • Planned major cardiac procedures such as left-sided transcatheter intervention or surgery, coronary artery bypass, PCI, or pulmonary valve correction (except ASD/PFO closure or electrophysiology procedures with 30-day delay)
  • Left ventricular ejection fraction 30% or less
  • Intracardiac, inferior vena cava, or femoral venous mass, thrombus, or vegetation
  • Tricuspid stenosis per echocardiographic criteria
  • Severe right ventricular dysfunction
  • Cardiac amyloidosis
  • Pulmonary artery systolic pressure over 65 mmHg
  • Lower extremity venous thrombosis or presence of inferior vena cava filter within 6 months
  • Significant pericardial effusion
  • Refractory heart failure requiring advanced interventions
  • Allergies to nitinol, bovine tissue, or contrast media not manageable with pre-medication
  • Inability to tolerate anticoagulation or antiplatelet therapy
  • Hemodynamic instability, cardiogenic shock, or acute heart failure within 30 days prior to procedure
  • Life-threatening condition with estimated survival less than 12 months
  • Platelet count below 75,000/mm3
  • Child-Pugh Class C liver disease
  • Severe renal insufficiency (eGFR 25 mL/min/1.73 m2 or less) or chronic renal replacement therapy
  • Active infection requiring antibiotics or endocarditis
  • Unable to walk at least 60 meters in six-minute walk test
  • Known bleeding or clotting disorders or refusal of blood transfusion
  • Active gastrointestinal bleeding within 3 months
  • Significant congenital heart disease
  • Participation in other investigational cardiovascular studies without reaching primary endpoint
  • Any condition precluding study requirements per investigator
  • Psychiatric, behavioral, medical, or social conditions preventing valid consent or follow-up
  • Pregnant or breastfeeding or planning pregnancy during study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 36 locations

1

St. Joseph's Hospital and Medical Center

Phoenix, Arizona, United States, 85013

Actively Recruiting

2

Tucson Medical Center

Tucson, Arizona, United States, 85712

Not Yet Recruiting

3

Scripps Memorial Hospital La Jolla

San Diego, California, United States, 92037

Actively Recruiting

4

UCSF

San Francisco, California, United States, 94143

Not Yet Recruiting

5

Delray Medical Center

Delray Beach, Florida, United States, 33484

Not Yet Recruiting

6

Largo Medical Center

Largo, Florida, United States, 33770

Actively Recruiting

7

Tampa General Hospital

Tampa, Florida, United States, 33606

Actively Recruiting

8

Endeavor Health, Glenbrook Hospital

Glenview, Illinois, United States, 60026

Actively Recruiting

9

Chicago Advocate Christ

Palos Park, Illinois, United States, 60464

Not Yet Recruiting

10

Ascension Medical Group St. Vincent The Heart Center of Indiana

Indianapolis, Indiana, United States, 46260

Actively Recruiting

11

Cardiovascular Institute of the South

Houma, Louisiana, United States, 70360

Actively Recruiting

12

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

13

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Not Yet Recruiting

14

Lahey Hospital & Medical Center

Burlington, Massachusetts, United States, 01805

Actively Recruiting

15

Minneapolis Heart Institute Foundation

Minneapolis, Minnesota, United States, 55407

Actively Recruiting

16

Saint Luke's Mid America Heart Institute

Kansas City, Missouri, United States, 64111

Not Yet Recruiting

17

Washington University St Louis

St Louis, Missouri, United States, 63110

Not Yet Recruiting

18

Hackensack University Medical Center

Hackensack, New Jersey, United States, 07601

Not Yet Recruiting

19

North Shore University Hospital

Manhasset, New York, United States, 11030

Not Yet Recruiting

20

Montefiore Medical Center

The Bronx, New York, United States, 10467

Actively Recruiting

21

Duke Cardiology Clinic

Durham, North Carolina, United States, 27710

Not Yet Recruiting

22

Cleveland Clinic

Cleveland, Ohio, United States, 44106

Actively Recruiting

23

Riverside Methodist Hospital

Columbus, Ohio, United States, 43214

Not Yet Recruiting

24

Oregon Health Services

Portland, Oregon, United States, 97239

Not Yet Recruiting

25

UPMC Pinnacle

Harrisburg, Pennsylvania, United States, 17107

Actively Recruiting

26

UPMC Presbyterian Shadyside

Pittsburgh, Pennsylvania, United States, 15232

Not Yet Recruiting

27

WellSpan York Hospital

York, Pennsylvania, United States, 17403

Not Yet Recruiting

28

MUSC

Charleston, South Carolina, United States, 29425

Not Yet Recruiting

29

Houston Methodist

Houston, Texas, United States, 77030

Actively Recruiting

30

University of Texas (Memorial Hermann)

Houston, Texas, United States, 77030

Actively Recruiting

31

Intermountain Heart Institute - Intermountain Medical Center

Murray, Utah, United States, 84107

Actively Recruiting

32

UVA School of Medicine

Charlottesville, Virginia, United States, 22903

Actively Recruiting

33

Sentara Healthcare

Norfolk, Virginia, United States, 23507

Not Yet Recruiting

34

Carilion Clinic

Roanoke, Virginia, United States, 24014

Not Yet Recruiting

35

MedStar Washington Hospital Center

Multiple Locations, Washington, United States, 20010

Actively Recruiting

36

Swedish Medical Center

Seattle, Washington, United States, 98122

Not Yet Recruiting

Loading map...

Research Team

M

Monica Tocchi, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) | DecenTrialz